Anúncio
Anúncio

NVAX

NVAX logo

Novavax Inc

7.44
USD
Patrocinado
+0.18
+2.55%
06 de jan., 15:59 UTC -5
Encerrado
exchange

Pré-Mercado

7.45

0.00
+0.07%

Relatórios de Lucros NVAX

Rácio de surpresa positiva

NVAX separação 17 de 40 últimas estimativas.

43%

Próximo Relatório

Data do Próximo Relatório
25 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$80.88M
/
-$0.49
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+14.81%
/
-60.80%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-8.41%
/
-40.96%

Novavax Inc earnings per share and revenue

On 06 de nov. de 2025, NVAX reported earnings of -1.25 USD per share (EPS) for Q3 25, missing the estimate of -1.21 USD, resulting in a -3.31% surprise. Revenue reached 70.44 milhão, compared to an expected 42.98 milhão, with a 63.92% difference. The market reacted with a -1.30% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analistas forecast an EPS of -0.49 USD, with revenue projected to reach 80.88 milhão USD, implying an diminuir of -60.80% EPS, and aumentar of 14.81% in Revenue from the last quarter.
FAQ
For Q3 2025, Novavax Inc reported EPS of -$1.25, missing estimates by -3.31%, and revenue of $70.44M, 63.92% above expectations.
The stock price moved down -1.3%, changed from $7.69 before the earnings release to $7.59 the day after.
The next earning report is scheduled for 25 de fev. de 2026.
Based on 10 analistas, Novavax Inc is expected to report EPS of -$0.49 and revenue of $80.88M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio